About Yuimedi
Yuimedi is a company based in Minato (Japan) founded in 2020. Yuimedi has raised $8.34 million across 4 funding rounds from investors including DG Daiwa Ventures, Aozora and Chiba Dojo. Yuimedi operates in a competitive market with competitors including MMIT Network, Posos, Memed, Wolters Kluwer Clinical Drug Information and Diagnosia, among others.
- Headquarter Minato, Japan
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$8.34 M (USD)
in 4 rounds
-
Latest Funding Round
$2.61 M (USD), Seed
Feb 18, 2026
-
Investors
DG Daiwa Ventures
& 9 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Yuimedi
Yuimedi has successfully raised a total of $8.34M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $2.61 million completed in February 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Yuimedi
Yuimedi has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include DG Daiwa Ventures, Aozora and Chiba Dojo.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments in blockchain, AI, and emerging technologies are managed.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
A robust entrepreneur community is supported in Chiba, Japan.
|
Locked | Locked | Locked |
Investor details for Yuimedi
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Yuimedi
Investment portfolio details for Yuimedi
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Yuimedi
Detailed financials for Yuimedi
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Yuimedi Comparisons
Peer comparison for Yuimedi
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Yuimedi
Yuimedi operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MMIT Network, Posos, Memed, Wolters Kluwer Clinical Drug Information and Diagnosia, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Offers formulary data & analytics for market research, medication decision & formulary management
|
|
| Locked | Locked | Locked |
AI-based drug information and patient profiling tool for healthcare professionals
|
|
| Locked | Locked | Locked |
Application with curated drug information used by physicians
|
|
| Locked | Locked | Locked |
Offers software and services for healthcare, tax, accounting, finance, and legal professionals.
|
|
| Locked | Locked | Locked |
Drug decision support engine is provided for healthcare professionals.
|
Detailed competitors of Yuimedi
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Yuimedi
Complete news archive for Yuimedi
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Yuimedi
Yuimedi was founded in 2020 and raised its 1st funding round 2 years after it was founded.
Yuimedi is headquartered in Minato, Japan. It is registered at Minato, Tokyo, Japan.
Emily Grimes is the current CEO of Yuimedi.
Yuimedi is a funded company, having raised a total of $8.34M across 4 funding rounds to date.
Provider of medical data analysis platform to improve the healthcare system. It offers a platform to support analytical research using medical data and prescription decisions by doctors and provides consulting on medical data, and operation services.
Yuimedi's top competitors include MMIT Network, Posos and Memed.
Yuimedi has 10 investors. Key investors include DG Daiwa Ventures, Aozora, Chiba Dojo, Nissay Capital, and D4V.